Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 58113-36-3 | MDL No. : | MFCD13192725 |
Formula : | C18H17F2N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KNNQGZBGAQFPCY-UHFFFAOYSA-N |
M.W : | 285.33 | Pubchem ID : | 2724436 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 84.77 |
TPSA : | 12.03 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.1 cm/s |
Log Po/w (iLOGP) : | 3.24 |
Log Po/w (XLOGP3) : | 4.14 |
Log Po/w (WLOGP) : | 4.61 |
Log Po/w (MLOGP) : | 4.62 |
Log Po/w (SILICOS-IT) : | 5.25 |
Consensus Log Po/w : | 4.37 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.51 |
Solubility : | 0.00886 mg/ml ; 0.000031 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.1 |
Solubility : | 0.0227 mg/ml ; 0.0000794 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -6.94 |
Solubility : | 0.0000329 mg/ml ; 0.000000115 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.56 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 92822-03-2 ]
4-(4-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.88
[ 6716-98-9 ]
4-(4-Fluorophenyl)piperidine hydrochloride
Similarity: 0.86
[ 193357-26-5 ]
4-(2-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.80
[ 92822-03-2 ]
4-(4-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.88
[ 6716-98-9 ]
4-(4-Fluorophenyl)piperidine hydrochloride
Similarity: 0.86
[ 193357-26-5 ]
4-(2-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.80
[ 1391361-52-6 ]
(R)-1-(4-Fluorophenyl)but-3-en-1-amine hydrochloride
Similarity: 0.71
[ 41354-29-4 ]
4-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine Sesquihydrate
Similarity: 0.67
[ 4630-95-9 ]
3-(Diphenylmethylene)-1,1-diethyl-2-methylpyrrolidin-1-ium bromide
Similarity: 0.59
[ 10563-70-9 ]
3-(10,10-Dimethylanthracen-9(10H)-ylidene)-N,N-dimethylpropan-1-amine hydrochloride
Similarity: 0.57
[ 92822-03-2 ]
4-(4-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.88
[ 6716-98-9 ]
4-(4-Fluorophenyl)piperidine hydrochloride
Similarity: 0.86
[ 193357-26-5 ]
4-(2-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.80
[ 92822-03-2 ]
4-(4-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.88
[ 6716-98-9 ]
4-(4-Fluorophenyl)piperidine hydrochloride
Similarity: 0.86
[ 193357-26-5 ]
4-(2-Fluorobenzyl)piperidine hydrochloride
Similarity: 0.80